NCT06734091 Rapid Processing and Immunohistochemistry Method for Optimising Diagnosis Time in Solid Organ Donors, Suspected Malignancy
| NCT ID | NCT06734091 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Donors |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2023-03-01 |
| Primary Completion | 2025-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2023-03-01 with a primary completion date of 2025-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Comparison of the diagnostic yield of intra-operative histological analysis of donor tissue with suspected neoplasia performed with the standard method versus the experimental method, which involves optimisation of sample freezing and analysis with the IHC fast track procedure
Eligibility Criteria
Inclusion Criteria: * Organ donors (legally dead by brain or cardiac death) with suspected neoplasia. * Sending organs/tissues of all types and locations for extemporaneous examination request Exclusion Criteria: * None
Contact & Investigator
Deborah Malvi, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06734091 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Donors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06734091 currently recruiting?
Yes, NCT06734091 is actively recruiting participants. Contact the research team at deborah.malvi@aosp.bo.it for enrollment information.
Where is the NCT06734091 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06734091 clinical trial?
NCT06734091 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Deborah Malvi, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 80 participants.